Cash Flow Statement
Quarterly Data

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Baxter International Inc., consolidated cash flow statement (quarterly data)

US$ in millions

3 months ended:	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015	Mar 31, 2015	Dec 31, 2014	Sep 30, 2014	Jun 30, 2014	Mar 31, 2014	Dec 31, 2013	Sep 30, 2013	Jun 30, 2013	Mar 31, 2013	Dec 31, 2012	Sep 30, 2012	Jun 30, 2012	Mar 31, 2012	Dec 31, 2011	Sep 30, 2011	Jun 30, 2011	Mar 31, 2011
Net income	1,212)	3,380)	205)	1)	332)	430)	953)	468)	520)	556)	326)	544)	590)	552)	494)	583)	661)	588)	472)	578)	629)	577)
(Income) loss from discontinued operations, net of tax	—)	7)	(22)	1)	(258)	(296)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Depreciation and amortization	206)	189)	166)	216)	190)	187)	258)	258)	253)	236)	250)	207)	183)	183)	178)	179)	180)	175)	167)	176)	169)	158)
Deferred income taxes	(76)	(71)	(113)	12)	3)	48)	(113)	66)	(14)	(17)	(309)	148)	(101)	38)	(214)	78)	65)	54)	(46)	58)	69)	91)
Stock compensation	31)	23)	30)	30)	37)	29)	44)	43)	41)	31)	39)	39)	40)	32)	33)	34)	35)	28)	25)	33)	33)	28)
Realized excess tax benefits from stock issued under employee benefit plans	—)	—)	(7)	—)	—)	—)	(3)	(4)	(5)	(12)	(2)	(13)	(7)	(12)	(10)	(6)	(1)	(7)	(4)	(4)	(8)	(5)
Business optimization items	—)	—)	28)	102)	—)	—)	3)	24)	(28)	28)	270)	12)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Net periodic pension benefit and OPEB costs	30)	30)	57)	55)	55)	60)	64)	70)	70)	71)	99)	95)	93)	94)	—)	—)	—)	—)	—)	—)	—)	—)
Net realized gains on Baxalta common stock	(1,148)	(3,239)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Gain on sale of discontinued operations	—)	—)	—)	—)	—)	—)	(466)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Infusion pump and other product-related charges	—)	—)	(28)	—)	—)	—)	—)	—)	93)	—)	17)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
(Gains) losses related to contingent payment liabilities	—)	—)	—)	—)	—)	—)	122)	—)	—)	—)	(17)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Impairment charge	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	182)	—)	—)	—)
Other	141)	97)	56)	(57)	(17)	(87)	52)	143)	89)	(15)	52)	(50)	42)	10)	323)	37)	(59)	(25)	121)	85)	10)	8)
Accounts and other current receivables, net	(54)	16)	(9)	(45)	—)	50)	(90)	(38)	(230)	233)	(106)	58)	(73)	85)	(113)	(42)	90)	24)	(127)	55)	(89)	(68)
Inventories	1)	(26)	87)	(35)	(48)	(122)	29)	(108)	(127)	(233)	101)	(106)	(125)	(181)	7)	(36)	(28)	(72)	(43)	(58)	(153)	(61)
Accounts payable and accrued liabilities	95)	(438)	222)	131)	189)	(306)	269)	68)	14)	(236)	385)	115)	128)	(299)	300)	(53)	59)	(288)	188)	34)	11)	(135)
Business optimization and infusion pump payments	(32)	(34)	(51)	(24)	(18)	(19)	(43)	(35)	(38)	(45)	(44)	(29)	(26)	(26)	(57)	(63)	(79)	(84)	(89)	(111)	(87)	(60)
Other	202)	(108)	(125)	(77)	(114)	(2)	64)	(41)	(39)	(38)	22)	(54)	19)	(90)	4)	36)	45)	53)	46)	76)	48)	(162)
Changes in balance sheet items	212)	(590)	124)	(50)	9)	(399)	229)	(154)	(420)	(319)	358)	(16)	(77)	(511)	141)	(158)	87)	(367)	(25)	(4)	(270)	(486)
Adjustments to reconcile income from continuing operations to net cash from operating activities	(604)	(3,554)	291)	309)	19)	(458)	190)	446)	79)	3)	757)	422)	173)	(166)	451)	164)	307)	(142)	420)	344)	3)	(206)
Cash flows from operations	608)	(174)	496)	310)	351)	(28)	1,143)	914)	599)	559)	1,083)	966)	763)	386)	945)	747)	968)	446)	892)	922)	632)	371)
Capital expenditures	(168)	(184)	(253)	(234)	(210)	(214)	(573)	(481)	(423)	(421)	(488)	(398)	(347)	(292)	(399)	(259)	(264)	(239)	(317)	(235)	(210)	(198)
Acquisitions and investments, net of cash acquired	(9)	(33)	(7)	(19)	(1)	(7)	(86)	(147)	(117)	(59)	(79)	(3,685)	(20)	(67)	(20)	(116)	(42)	(337)	(361)	(27)	(188)	(14)
Divestitures and other investing activities	8)	3)	28)	38)	14)	4)	662)	9)	(2)	96)	—)	4)	—)	10)	21)	12)	31)	43)	17)	—)	106)	—)
Cash flows from investing activities	(169)	(214)	(232)	(215)	(197)	(217)	3)	(619)	(542)	(384)	(567)	(4,079)	(367)	(349)	(398)	(363)	(275)	(533)	(661)	(262)	(292)	(212)
Issuances of debt	—)	61)	—)	121)	5,847)	900)	—)	7)	2)	32)	138)	9)	3,481)	8)	15)	1,010)	—)	12)	502)	—)	2)	2)
Payments of obligations	(246)	(20)	(63)	(2,769)	(326)	(618)	(503)	—)	(16)	(510)	(14)	(222)	(3)	(301)	(4)	(13)	(2)	(3)	(14)	(2)	(4)	(3)
Increase (decrease) in debt with original maturities of three months or less, net	31)	450)	(125)	425)	(1,236)	361)	525)	200)	150)	—)	—)	—)	(300)	300)	—)	(375)	75)	50)	175)	75)	—)	—)
Transfer of cash and equivalents to Baxalta	—)	—)	—)	(2,122)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Cash dividends on common stock	(63)	(63)	(63)	(283)	(282)	(282)	(282)	(282)	(265)	(266)	(266)	(267)	(244)	(246)	(246)	(184)	(186)	(188)	(175)	(176)	(178)	(180)
Proceeds and realized excess tax benefits from stock issued under employee benefit plans	96)	99)	26)	55)	71)	48)	49)	71)	111)	138)	40)	127)	145)	196)	205)	127)	19)	161)	43)	101)	170)	134)
Purchases of treasury stock	—)	—)	—)	—)	—)	—)	(50)	(50)	(200)	(250)	(50)	(146)	(183)	(534)	(415)	(105)	(385)	(575)	(170)	(298)	(478)	(637)
Other	—)	(17)	(3)	(12)	(2)	(25)	(14)	(1)	(2)	4)	2)	(1)	(1)	(23)	(6)	—)	(97)	(5)	(6)	(6)	(10)	(4)
Cash flows from financing activities	(182)	510)	(228)	(4,585)	4,072)	384)	(275)	(55)	(220)	(852)	(150)	(500)	2,895)	(600)	(451)	460)	(576)	(548)	355)	(306)	(498)	(688)
Cash flows from operations, discontinued operations	167)	(159)	228)	(179)	345)	124)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Cash flows from investing activities, discontinued operations	—)	13)	—)	—)	(393)	(553)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Cash flows from discontinued operations	167)	(146)	228)	(179)	(48)	(429)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Effect of foreign exchange rate changes on cash and equivalents	(5)	22)	(21)	(41)	(28)	(105)	(24)	(28)	(20)	(7)	(9)	—)	9)	(18)	(17)	(6)	(36)	2)	(19)	(34)	8)	12)
Increase (decrease) in cash and equivalents	419)	(2)	243)	(4,710)	4,150)	(395)	847)	212)	(183)	(684)	357)	(3,613)	3,300)	(581)	79)	838)	81)	(633)	567)	320)	(150)	(517)

The financial data exhibit evident fluctuations and notable events impacting the company’s quarterly performance over the observed period.

Net Income: Net income shows variability with some quarters experiencing strong results, particularly notable are the spikes in March 31, 2015, June 30, 2016, and surrounding quarters. However, sharp declines occur in specific quarters such as December 31, 2013, likely influenced by discontinued operations and other unique items.
Income (Loss) from Discontinued Operations: Discontinued operations have had a significant negative impact during certain periods, especially noticeable in 2014 and early 2015. These losses skew the overall net income, affecting reported profitability.
Depreciation and Amortization: Depreciation and amortization expenses have remained relatively stable with a gradual increase over the years, reaching a peak in late 2013 and maintaining elevated levels subsequently, which is typical as asset base growth or impairment charges are recognized.
Deferred Income Taxes: Deferred tax figures fluctuated markedly, showing both positive and large negative values, reflecting tax timing differences and possibly tax attribute utilizations or adjustments linked to discontinued operations or restructuring.
Stock Compensation and Tax Benefits: Stock compensation costs have been stable but relatively modest in size. Realized excess tax benefits aligned with stock issuance fluctuate negatively, indicating tax planning impacts or timing differences in recognizing these benefits.
Business Optimization Items and Other Special Charges: There is a presence of significant one-off items and optimization costs, especially visible in late 2013 with a large business optimization inflow, and infusion pump-related charges appearing sporadically. Such items contribute to fluctuations in earnings and require adjustment to assess underlying operational performance.
Other Operations and Working Capital Changes: Working capital components such as accounts receivable, inventories, and payables exhibited volatility, implying variable operational cash flows and inventory management challenges. Notably, large swings in accounts payable and accrued liabilities suggest timing-related payment strategies or supply chain adjustments.
Cash Flows from Operations and Investing: Operational cash flow is generally positive but variable, with some quarters reflecting strong cash generation (notably 2013 and 2014) while others show contractions. Capital expenditures have increased consistently, highlighting investments in asset base expansion or maintenance. Investing activities include significant acquisition outlays, especially in 2013 at September quarter, aligning with strategic growth moves.
Financing Activities: Financing cash flows reveal considerable complexity with debt issuances and repayments varying widely, including large debt raises in mid-2013 and mid-2015, possibly related to funding acquisitions or refinancing. Treasury stock purchases remained substantial but decreased over time, implying active share repurchase programs. Dividends showed steady payouts signaling a commitment to returning capital to shareholders.
Discontinued Operations and Foreign Exchange: Discontinued operations considerably impacted cash flows in 2014 and 2015, with significant cash outflows and inflows suggesting divestitures or restructuring activities. Foreign exchange impacts are relatively small but consistent, reflecting global operational exposure.
Overall Cash Position: Changes in cash and equivalents show high volatility, with large positive changes in mid-2013 and mid-2015 and steep declines elsewhere, illustrating the effects of non-operating factors such as acquisitions, divestitures, and financing activities on liquidity management.

In summary, the company's financial performance across the quarterly periods reviewed is characterized by inconsistencies due to strategic restructuring, discontinued operations, and strong capital investment and financing activities. These factors combined suggest a dynamic operational environment with significant efforts toward optimization and portfolio management driving fluctuating financial results and cash flow patterns.

Download chart

Baxter International Inc. (NYSE:BAX)

Cash Flow Statement Quarterly Data

Cash Flow Statement
Quarterly Data